Регистрация | Вход в службу | FAQ      [?] 

Cardiac Electrophysiology Review

Статьи последних нескольких выпусков журнала Cardiac Electrophysiology Review © Springer
  • Editorial: The Future of Cardiac Electrophysiology Review
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 311-311.
    by KP Anderson
  • Selection of Pacing Mode after Interruption of Atrioventricular Conduction for Atrial Fibrillation: Observations from the PA3 Clinical Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 312-314.
    by AM Gillis
  • Comparison of Permanent Left Ventricular and Biventricular Pacing in Patients with Heart Failure and Chronic Atrial Fibrillation: A Prospective Hemodynamic Study
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 315-324.
    by S Garrigue, P Bordachar, S Reuter, P Jais, M Haissaguerre, J Clementy
  • Is Bachmanns Bundle the Only Right Site for Single-Site Pacing to Prevent Atrial Fibrillation? Results of a Multicenter Randomized Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 325-328.
    by SJ Bailin
  • Multisite Atrial Pacing for Atrial Fibrillation Prevention: Where to Go from Here?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 329-332.
    by AR Misier, WP Beukema, R Willems
  • Detection of Atrial Fibrillation by Permanent Pacemakers: Observations from the STOP AF Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 333-340.
    by CJ Plummer, JM Mccomb
  • Effectiveness of Rapid Atrial Pacing for Termination of Drug Refractory Atrial Fibrillation: Results of a Dual Chamber Implantable Cardioverter Defibrillator Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 341-344.
    by MR Gold, RB Leman, DE Euler
  • Atrial Pacing Therapies for Prevention of Atrial Fibrillation in Patients with Implantable Defibrillators
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 345-347.
    by AM Gillis
  • Efficacy of Atrial Antitachycardia Functions for Treating Atrial Fibrillation: Observations in Patients with a Dual-Chamber Defibrillator
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 348-351.
    by R Ricci, C Pignalberi, M Santini
  • Does Rapid Atrial Pacing Terminate Atrial Fibrillation? A Comparison of Laboratory and Device Termination Studies
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 352-354.
    by ARJ Mitchell, N Sulke
  • Atrial Arrhythmia Burden as an Endpoint in Clinical Trials: Is it the Best Surrogate? Lessons from a Multicenter Defibrillator Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 355-358.
    by DE Euler, PA Friedman
  • Does Sinus Rhythm Beget Sinus Rhythm? Effects of Prompt Cardioversion on the Frequency and Persistence of Recurrent Atrial Fibrillation
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 359-365.
    by HF Tse, CP Lau
  • AFFIRM and RACE Trials: Implications for the Management of Atrial Fibrillation
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 366-369.
    by JL Blackshear, RE Safford
  • Atrial Fibrillation: Should we Target Platelets or the Coagulation Pathway?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 370-371.
    by KT Tan, GYH Lip
    posted by 1 person pgogineni
  • Aspirin-Anticoagulant Combination in Patients with Non Valvular Atrial Fibrillation Commentary on the FFAACS Study Results
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 372-373.
    by PP Lechat
  • Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 374-378.
    by C van Walraven, RG Hart, DE Singer, PJ Koudstaal, S Connolly
  • Do Anticoagulation Management Services Improve Care? Implications of the Managing Anticoagulation Services Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 379-381.
    by DB Matchar
  • Use of Subcutaneous Enoxaparin Compared to Intravenous Heparin and Oral Phenprocoumon in the Setting of Cardioversion-The ACE Study (Anticoagulation in Cardioversion Using Enoxaparin)
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 382-386.
    by C Stellbrink, U Nixdorff, T Hofmann, W Lehmacher, WG Daniel, P Hanrath, C Geller, A Mugge, W Sehnert, C Schmidt-Lucke, JA Schmidt-Lucke, On
  • Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation: ACUTE Trial Update
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 387-391.
    by CR Asher, AL Klein
  • Cardioversion Related Thromboembolism: Value of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 392-396.
    by K Seidl, J Senges
  • Low Molecular Weight Heparin in Atrial Fibrillation Management: Facts, Fiction, Future
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 397-400.
    by MH Kim, RG Trohman, KA Eagle
  • Relationships between Pacing Mode and Quality of Life: Evidence from Randomized Clinical Trials
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 401-405.
    by D Newman
  • Selecting the Appropriate Pacing Mode for Patients with Sick Sinus Syndrome: Evidence from Randomized Clinical Trials
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 406-410.
    by AE Albertsen, JC Nielsen
  • Second Vasovagal Pacemaker Study (VPS II): Rationale, Design, Results, and Implications for Practice and Future Clinical Trials
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 411-415.
    by R Sheldon, S Connolly
  • Pacing for Vasovagal Syncope After the Second Vasovagal Pacemaker Study (VPS II): A Matter of Judgement
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 416-420.
    by GM Trim, AD Krahn, GJ Klein, AC Skanes, R Yee
  • Cardiac Resynchronization Therapy with or without an Implantable Defibrillator: Only Indicated When Everything Else has Failed?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 421-429.
    by J Ghosh, G Kaye, JGF Cleland
  • MADIT-II: Substudies and Their Implications
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 430-433.
    by AJ Moss
  • Risk Stratification for Sudden Death: Do We Need Anything More Than Ejection Fraction?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 434-437.
    by AE Buxton
  • Enhancing Specificity Without Sacrificing Sensitivity: Potential Benefits of Using Microvolt T-Wave Alternans Testing to Risk Stratify the MADIT-II Population
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 438-442.
    by RJ Cohen
  • Using the MADIT II Criteria for Implantable Cardioverter Defibrillators-What is the Role of the Food and Drug Administration Approval?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 443-446.
    by HS Barold
  • The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Rationale, Design and Specific Aims
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 447-451.
    by G Gronefeld, SJ Connolly, SH Hohnloser, On
    posted by 2 people brocktice TulaneCEP
  • Amiodarone versus Implantable Defibrillator (AMIOVIRT): Background, Rationale, Design, Methods, Results and Implications
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 452-456.
    by M Wijetunga, SA Strickberger
  • DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 457-462.
    by A Schaechter, AH Kadish
  • Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy: What have We Learned and What can We Expect from Future Trials?
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 463-467.
    by W Grimm
  • The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: Rationale, Design, Results, Clinical Implications and Lessons for Future Trials
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 468-472.
    by BL Wilkoff, The
  • Clinical Significance of Device-Related Complications in Clinical Trials and Implications for Future Trials: Insights from the Antiarrhytmics versus Implantable Defibrillators (AVID) Trial
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 473-478.
    by J Kron
  • Cost-Effectiveness of the Implantable Cardioverter Defibrillator
    Cardiac Electrophysiology Review, Vol. 7, No. 4. (December 2003), pp. 479-482.
    by MA Hlatky, GD Sanders, DK Owens
    • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/journal/klu-cepr

    RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.